Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Jan 5;30(1):27–33. doi: 10.1297/cpe.30.27

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

2021©The Japanese Society for Pediatric Endocrinology

This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License. (CC-BY-NC-ND 4.0: http://creativecommons.org/licenses/by-nc-nd/4.0/）.

PMC Copyright notice

Fig. 2. — Change in percentages of patients with each C-peptide immunoreactivity (CPR) level according to the duration (yr) since diagnosis in type 1A diabetes mellitus (T1AD) children. Fifty-two subjects were diagnosed with T1AD for 1 yr since diagnosis, 158 for 1–3 yr since diagnosis, 120 for 3–5 yr since diagnosis, 195 for 5–10 yr since diagnosis, and 51 for 10–16 yr since diagnosis. The percentage of children with a CPR < 0.1 ng/mL increased according to the duration since diagnosis (P < 0.001): 15% for within 1 yr, 30% for 1–3 yr, 51% for 3–5 yr, 66% for 5–10 yr, and 78% for 10–16 yr. At 5 or more years since diagnosis, 69% (167/246) had a CPR < 0.1 and 95% (233/246) had a CPR < 0.3 ng/mL.